Quality Control of Esophagogastroduodenoscopy Using Real-time EGD Auxiliary System
Utilization of Real-time Automatic Quality-control System in the Detection of Gastric Neoplasms
1 other identifier
interventional
1,060
1 country
1
Brief Summary
The aim of our study was to develop an automatic quality-control system and assess the performance of this system in quality control of esophagogastroduodenoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2019
CompletedFirst Posted
Study publicly available on registry
March 20, 2019
CompletedStudy Start
First participant enrolled
March 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2019
CompletedJanuary 30, 2020
January 1, 2020
8 months
March 19, 2019
January 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
detection rate of gastric neoplasms
detection rate of gastric neoplasms in different groups
8 months
Secondary Outcomes (4)
mean number of gastric neoplasms detected
8 months
mean inspection completeness
8 months
mean inspection time
8 months
errors of EAS
8 months
Study Arms (2)
EAS-aided group
EXPERIMENTALesophagogastroduodenoscopy examination with the assistance of automatic quality-control system
control group
NO INTERVENTIONconventional standard esophagogastroduodenoscopy examination without the assistance of automatic quality-control system
Interventions
Automatic quality-control system could real-time measuring endoscopic inspection completeness, detecting gastric neoplasms and evaluating gastric mucosal visibility.
Eligibility Criteria
You may qualify if:
- patients undergoing EGD examination with anaesthesia;
- patients able to give informed consent.
You may not qualify if:
- patients with the contraindications to EGD examination;
- patients with a prior EGD examination within 1 year before the trial;
- patients with frankly upper gastrointestinal malignant lesions that were apparent on endoscopy;
- a history of upper gastrointestinal cancers;
- allergic to anaesthetic in previous medical history;
- patients refused to participate in the trial;
- the EGD procedure cannot be completed due to stenosis, obstruction, solid food, or complications of anaesthesia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yanqing Lilead
Study Sites (1)
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, 250012, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- vice president of Qilu Hospital
Study Record Dates
First Submitted
March 19, 2019
First Posted
March 20, 2019
Study Start
March 20, 2019
Primary Completion
October 31, 2019
Study Completion
October 31, 2019
Last Updated
January 30, 2020
Record last verified: 2020-01